Heart Test Laboratories, Inc. Stock
Equities
HSCS
US42254E3027
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.83 USD | +1.57% | +6.00% | -65.91% |
Financials (USD)
Sales 2024 * | 59.3K | Sales 2025 * | 1.9M | Capitalization | 3.82M |
---|---|---|---|---|---|
Net income 2024 * | -6M | Net income 2025 * | -9M | EV / Sales 2024 * | 64.5 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.01 x |
P/E ratio 2024 * |
-0.29
x | P/E ratio 2025 * |
-0.56
x | Employees | 12 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.99% |
1 day | +1.57% | ||
1 week | +6.00% | ||
Current month | +6.00% | ||
1 month | -35.15% | ||
3 months | -52.10% | ||
6 months | -63.61% | ||
Current year | -65.91% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Simpson
CEO | Chief Executive Officer | 55 | 13-07-24 |
Danielle Watson
DFI | Director of Finance/CFO | 42 | 21-10-31 |
Aaron Peterson
CTO | Chief Tech/Sci/R&D Officer | - | 14-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Hilz
COO | Chief Operating Officer | 66 | 13-07-24 |
David R. Wells
BRD | Director/Board Member | 61 | 22-12-27 |
Andrew Simpson
CEO | Chief Executive Officer | 55 | 13-07-24 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 5.83 | +1.57% | 34,973 |
24-06-06 | 5.74 | +3.42% | 34,326 |
24-06-05 | 5.55 | +7.77% | 47,825 |
24-06-04 | 5.15 | -9.49% | 112,775 |
24-06-03 | 5.69 | +3.45% | 61,529 |
Delayed Quote Nasdaq, June 07, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-65.91% | 3.82M | |
-10.63% | 2.98B | |
-7.11% | 170M | |
-13.75% | 83.64M |
- Stock Market
- Equities
- HSCS Stock